查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1576812

基因分析市場：按技術、應用、最終用戶、產品類型、工作流程分類 - 2025-2030 年全球預測

Genetic Analysis Market by Technology (Capillary Electrophoresis, CRISPR, Mass Spectrometry), Application (Agricultural Genetics, Animal Genetics, Clinical Diagnostics), End User, Product, Sample Type, Workflow - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，基因分析市值為102.4億美元，預計到2024年將達到109.4億美元，複合年成長率為6.90%，到2030年將達到163.4億美元。

遺傳分析是透過研究 DNA、RNA 和蛋白質來了解基因的結構和功能，在醫療保健、農業和生物技術領域發揮至關重要的作用。作為精準醫學的基石，它可以根據個人的遺傳特徵提供量身定做的治療方法。遺傳分析的需求源自於能夠深入了解遺傳疾病、促進藥物開發和最佳化農業生產，從而解決醫療保健和糧食安全的重要挑戰。全球遺傳分析市場受到技術進步、基因組序列測定成本降低以及對研發的日益關注的顯著影響。新興的基因組學市場預計將大大受益於 CRISPR 技術和次世代定序等技術創新，為相關人員提供投資和擴大在這些高成長領域的足跡的機會。然而，市場面臨倫理問題、資料隱私問題以及基因資料的高度複雜性等挑戰，阻礙了廣泛採用。此外，缺乏嚴格的法律規範和標準化通訊協定也阻礙了市場的成長。儘管存在這些挑戰，但透過與研究機構和醫療保健提供者合作開發綜合遺傳資料庫和分析平台，仍有很大的擴展機會。具有巨大潛力的創新領域包括生物資訊學、個人化基因治療和合成生物學，這些領域有望促進疾病預防和介入策略的突破。市場相關人員應專注於利用人工智慧和機器學習進行資料分析和改進預測基因組學模型。為了最大限度地提高成長前景，公司應主動應對監管環境，確保合規性，並解決與使用遺傳資料相關的道德問題。透過專注於這些策略重點，公司可以利用基因分析的變革力量來塑造未來的醫療保健和農業範例。

主要市場統計
基準年[2023] 102.4億美元
預測年份 [2024] 109.4億美元
預測年份 [2030] 163.4億美元
複合年成長率（%） 6.90%

市場動態：快速發展的基因分析市場的關鍵市場洞察

供需的動態交互作用正在改變基因分析市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 擴大遺傳分析在個人化醫療和標靶治療中的作用
    • 政府對基因組研究和公共衛生計畫的計劃和資助
    • 學術機構與生技公司合作促進基因研究
    • 消費者對消費者基因檢測服務的興趣日益濃厚，以深入了解家族歷史和健康狀況
  • 市場限制因素
    • 人們越來越擔心基因檢測結果的變異性和準確性
    • 由於技術的快速進步和主要企業之間的激烈競爭，市場進入障礙
  • 市場機會
    • 擴大基因檢測在農業的應用，以促進作物改良和害蟲抗性
    • 開發用於藥物發現和個人化治療計劃的基因分析工具
    • 利用遺傳見解進行精密農業和永續農業實踐
  • 市場挑戰
    • 將遺傳分析與現有醫療保健系統整合的複雜性、資料互通性問題
    • 遺傳分析領域的專業知識和勞動力有限影響市場成長

波特五力：駕馭基因分析市場的策略工具

波特的五力架構是了解基因分析市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解遺傳分析市場的外部影響

外部宏觀環境因素在塑造基因分析市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解基因分析市場的競爭狀況

遺傳分析市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣遺傳分析市場供應商績效評估

FPNV定位矩陣是評估基因分析市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製基因分析市場的成功之路

基因分析市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 擴大遺傳分析在個人化醫療和標靶治療中的作用
      • 政府對基因組研究和公共衛生計畫的計劃和資助
      • 學術機構和生物技術公司合作推進基因研究
      • 消費者對消費者基因檢測服務的興趣日益濃厚，以深入了解血統和健康狀況
    • 抑制因素
      • 人們對基因檢測結果的變異性和準確性的擔憂日益增加
      • 由於技術的快速進步和主要參與者之間的激烈競爭導致市場進入障礙
    • 機會
      • 擴大基因檢測在農業的應用，以促進作物改良和害蟲抗性
      • 開發用於藥物發現和個人化治療計劃的基因分析工具
      • 利用遺傳知識進行精密農業和永續農業實踐
    • 任務
      • 將遺傳分析與現有醫療保健系統整合的複雜性和資料互通性問題
      • 遺傳分析領域的專業知識和勞動力有限影響市場成長
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 基因分析市場：依技術分類

  • 毛細管電泳
  • 更脆
  • 質譜分析
  • 微陣列
  • 次世代定序
  • 聚合酵素鏈鎖反應
  • 聚合酵素鏈鎖反應(PCR)
    • 數位PCR
    • 即時PCR
  • 單細胞基因體學

第7章 基因分析市場：依應用分類

  • 農業遺傳學
  • 動物遺傳學
  • 臨床診斷
    • 癌症診斷
    • 遺傳疾病診斷
    • 感染疾病
  • 法醫學
  • 製藥/生物技術
  • 調查

第8章 基因分析市場：依最終使用者分類

  • 診斷實驗室
  • 法醫學研究所
  • 醫院/診所
  • 製藥和生物技術公司
  • 研究中心和學術機構

第9章基因分析市場：依產品

  • 裝置
  • 試劑/耗材
  • 軟體和服務

第10章按樣本類型分類的基因分析市場

  • 血
  • 骨
  • 唾液
  • 組織

第11章基因分析市場：依工作流程

  • 資料分析
  • 前序
  • 定序

第12章北美和南美的基因分析市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第13章亞太地區基因分析市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第14章歐洲、中東和非洲基因分析市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-1A1A064C059E

The Genetic Analysis Market was valued at USD 10.24 billion in 2023, expected to reach USD 10.94 billion in 2024, and is projected to grow at a CAGR of 6.90%, to USD 16.34 billion by 2030.

Genetic analysis, which encompasses studying DNA, RNA, and proteins to understand genetic structures and functions, has a pivotal role across healthcare, agriculture, and biotechnology sectors, driving innovations in personalized medicine, disease diagnostics, and crop improvement. It serves as a cornerstone in precision medicine, enabling tailored therapeutic approaches based on individual genetic profiles. The necessity of genetic analysis arises from its ability to provide insights into genetic disorders, facilitate drug development, and optimize agricultural outputs, thereby addressing crucial healthcare and food security challenges. The global market for genetic analysis is influenced significantly by technological advancements, the decreasing cost of genome sequencing, and a rising focus on research and development. Emerging markets in genomics are expected to benefit greatly from innovations such as CRISPR technology and next-generation sequencing, offering opportunities for stakeholders to expand their footprints by investing in these high-growth areas. However, the market faces challenges such as ethical concerns, data privacy issues, and the high complexity of genetic data which can hinder widespread adoption. Additionally, stringent regulatory frameworks and a lack of standardized protocols pose obstacles to market growth. Despite these challenges, there are substantial opportunities for business expansion through collaborations with research institutions and healthcare providers, aimed at developing comprehensive genetic databases and analytics platforms. Innovation areas with vast potential include bioinformatics, personalized gene therapies, and synthetic biology, which promise to catalyze breakthroughs in disease prevention and intervention strategies. Market players should focus on leveraging AI and machine learning for data analysis to refine predictive models in genomics. To maximize growth prospects, companies should navigate the regulatory landscape proactively, ensuring compliance and addressing ethical concerns related to genetic data usage. By focusing on these strategic priorities, businesses can harness the transformative power of genetic analysis in shaping future healthcare and agricultural paradigms.

KEY MARKET STATISTICS
Base Year [2023] USD 10.24 billion
Estimated Year [2024] USD 10.94 billion
Forecast Year [2030] USD 16.34 billion
CAGR (%) 6.90%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Genetic Analysis Market

The Genetic Analysis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Expanding role of genetic analysis in personalized healthcare and targeted therapies
    • Government initiatives and funding support for genomic research and public health programs
    • Collaboration between academic institutions and biotech companies fostering genetic research
    • Increasing consumer interest in direct-to-consumer genetic testing services for ancestry and health insights
  • Market Restraints
    • Growing concerns regarding the variability and accuracy of genetic testing results
    • Barriers to market entry due to rapid technological advancement and intense competition among key players
  • Market Opportunities
    • Expansion of genetic testing applications in agriculture for crop improvement and pest resistance
    • Development of genetic analysis tools for drug discovery and personalized treatment plans
    • Utilization of genetic insights for precision farming and sustainable agricultural practices
  • Market Challenges
    • Integration complexities of genetic analysis with existing healthcare systems and data interoperability issues
    • Limited expertise and workforce in the field of genetic analysis impacting market growth

Porter's Five Forces: A Strategic Tool for Navigating the Genetic Analysis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Genetic Analysis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Genetic Analysis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Genetic Analysis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Genetic Analysis Market

A detailed market share analysis in the Genetic Analysis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Genetic Analysis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Genetic Analysis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Genetic Analysis Market

A strategic analysis of the Genetic Analysis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Genetic Analysis Market, highlighting leading vendors and their innovative profiles. These include 23andMe, Inc., Adaptive Biotechnologies Corporation, Agilent Technologies, Inc., Beckman Coulter, Inc., BGI Group, Bio-Rad Laboratories, Inc., Eurofins Scientific, F. Hoffmann-La Roche Ltd., Genewiz, Inc., Genomic Health, Inc., Guardant Health, Inc., Illumina, Inc., Invitae Corporation, Myriad Genetics, Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California, Inc., PerkinElmer, Inc., Personalis, Inc., QIAGEN N.V., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Genetic Analysis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Capillary Electrophoresis, CRISPR, Mass Spectrometry, Microarray, Next-Generation Sequencing, Polymerase Chain Reaction, Polymerase Chain Reaction (PCR), and Single-Cell Genomics. The Polymerase Chain Reaction (PCR) is further studied across Digital PCR and Real-Time PCR.
  • Based on Application, market is studied across Agricultural Genetics, Animal Genetics, Clinical Diagnostics, Forensic Science, Pharmaceutical & Biotechnology, and Research. The Clinical Diagnostics is further studied across Cancer Diagnostics, Genetic Disease Diagnostics, and Infectious Diseases.
  • Based on End User, market is studied across Diagnostic Laboratories, Forensic Laboratories, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research Centers & Academic Institutions.
  • Based on Product, market is studied across Instruments, Reagents & Consumables, and Software & Services.
  • Based on Sample Type, market is studied across Blood, Bone, Saliva, and Tissue.
  • Based on Workflow, market is studied across Data Analysis, Pre-Sequencing, and Sequencing.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Expanding role of genetic analysis in personalized healthcare and targeted therapies
      • 5.1.1.2. Government initiatives and funding support for genomic research and public health programs
      • 5.1.1.3. Collaboration between academic institutions and biotech companies fostering genetic research
      • 5.1.1.4. Increasing consumer interest in direct-to-consumer genetic testing services for ancestry and health insights
    • 5.1.2. Restraints
      • 5.1.2.1. Growing concerns regarding the variability and accuracy of genetic testing results
      • 5.1.2.2. Barriers to market entry due to rapid technological advancement and intense competition among key players
    • 5.1.3. Opportunities
      • 5.1.3.1. Expansion of genetic testing applications in agriculture for crop improvement and pest resistance
      • 5.1.3.2. Development of genetic analysis tools for drug discovery and personalized treatment plans
      • 5.1.3.3. Utilization of genetic insights for precision farming and sustainable agricultural practices
    • 5.1.4. Challenges
      • 5.1.4.1. Integration complexities of genetic analysis with existing healthcare systems and data interoperability issues
      • 5.1.4.2. Limited expertise and workforce in the field of genetic analysis impacting market growth
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Genetic Analysis Market, by Technology

  • 6.1. Introduction
  • 6.2. Capillary Electrophoresis
  • 6.3. CRISPR
  • 6.4. Mass Spectrometry
  • 6.5. Microarray
  • 6.6. Next-Generation Sequencing
  • 6.7. Polymerase Chain Reaction
  • 6.8. Polymerase Chain Reaction (PCR)
    • 6.8.1. Digital PCR
    • 6.8.2. Real-Time PCR
  • 6.9. Single-Cell Genomics

7. Genetic Analysis Market, by Application

  • 7.1. Introduction
  • 7.2. Agricultural Genetics
  • 7.3. Animal Genetics
  • 7.4. Clinical Diagnostics
    • 7.4.1. Cancer Diagnostics
    • 7.4.2. Genetic Disease Diagnostics
    • 7.4.3. Infectious Diseases
  • 7.5. Forensic Science
  • 7.6. Pharmaceutical & Biotechnology
  • 7.7. Research

8. Genetic Analysis Market, by End User

  • 8.1. Introduction
  • 8.2. Diagnostic Laboratories
  • 8.3. Forensic Laboratories
  • 8.4. Hospitals & Clinics
  • 8.5. Pharmaceutical & Biotechnology Companies
  • 8.6. Research Centers & Academic Institutions

9. Genetic Analysis Market, by Product

  • 9.1. Introduction
  • 9.2. Instruments
  • 9.3. Reagents & Consumables
  • 9.4. Software & Services

10. Genetic Analysis Market, by Sample Type

  • 10.1. Introduction
  • 10.2. Blood
  • 10.3. Bone
  • 10.4. Saliva
  • 10.5. Tissue

11. Genetic Analysis Market, by Workflow

  • 11.1. Introduction
  • 11.2. Data Analysis
  • 11.3. Pre-Sequencing
  • 11.4. Sequencing

12. Americas Genetic Analysis Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Genetic Analysis Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Genetic Analysis Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 23andMe, Inc.
  • 2. Adaptive Biotechnologies Corporation
  • 3. Agilent Technologies, Inc.
  • 4. Beckman Coulter, Inc.
  • 5. BGI Group
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Eurofins Scientific
  • 8. F. Hoffmann-La Roche Ltd.
  • 9. Genewiz, Inc.
  • 10. Genomic Health, Inc.
  • 11. Guardant Health, Inc.
  • 12. Illumina, Inc.
  • 13. Invitae Corporation
  • 14. Myriad Genetics, Inc.
  • 15. Oxford Nanopore Technologies plc
  • 16. Pacific Biosciences of California, Inc.
  • 17. PerkinElmer, Inc.
  • 18. Personalis, Inc.
  • 19. QIAGEN N.V.
  • 20. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GENETIC ANALYSIS MARKET RESEARCH PROCESS
  • FIGURE 2. GENETIC ANALYSIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENETIC ANALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. GENETIC ANALYSIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. GENETIC ANALYSIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENETIC ANALYSIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENETIC ANALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENETIC ANALYSIS MARKET DYNAMICS
  • TABLE 7. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY CRISPR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SINGLE-CELL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY AGRICULTURAL GENETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY ANIMAL GENETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY GENETIC DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY FORENSIC SCIENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY FORENSIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY RESEARCH CENTERS & ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY BONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY TISSUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY PRE-SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL GENETIC ANALYSIS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 76. CANADA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES GENETIC ANALYSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 118. CHINA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 126. INDIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 140. JAPAN GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. JAPAN GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 142. JAPAN GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. JAPAN GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 148. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 150. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 152. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 156. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 158. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 160. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 164. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 166. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 168. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 176. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 180. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 182. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 184. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. TAIWAN GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 188. THAILAND GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. THAILAND GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 190. THAILAND GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. THAILAND GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 192. THAILAND GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. THAILAND GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. THAILAND GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. THAILAND GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 196. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 198. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 200. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. VIETNAM GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA GENETIC ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 213. DENMARK GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. DENMARK GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 215. DENMARK GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. DENMARK GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 217. DENMARK GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. DENMARK GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. DENMARK GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. DENMARK GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 221. EGYPT GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. EGYPT GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 223. EGYPT GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. EGYPT GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 225. EGYPT GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. EGYPT GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. EGYPT GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. EGYPT GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 229. FINLAND GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. FINLAND GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 231. FINLAND GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. FINLAND GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 233. FINLAND GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 234. FINLAND GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. FINLAND GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. FINLAND GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 237. FRANCE GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 238. FRANCE GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 239. FRANCE GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. FRANCE GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 241. FRANCE GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 242. FRANCE GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 243. FRANCE GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. FRANCE GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 245. GERMANY GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 246. GERMANY GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 247. GERMANY GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 248. GERMANY GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 249. GERMANY GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 250. GERMANY GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 251. GERMANY GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. GERMANY GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 253. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 254. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 255. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 257. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 258. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 259. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. ISRAEL GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 261. ITALY GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 262. ITALY GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 263. ITALY GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. ITALY GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 265. ITALY GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 266. ITALY GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 267. ITALY GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. ITALY GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 270. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 272. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 274. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. NETHERLANDS GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 277. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 278. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 279. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 281. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 282. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 283. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. NIGERIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 285. NORWAY GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 286. NORWAY GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 287. NORWAY GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 288. NORWAY GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 289. NORWAY GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 290. NORWAY GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 291. NORWAY GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 292. NORWAY GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 293. POLAND GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 294. POLAND GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 295. POLAND GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 296. POLAND GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 297. POLAND GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 298. POLAND GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 299. POLAND GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 300. POLAND GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 301. QATAR GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 302. QATAR GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 303. QATAR GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 304. QATAR GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 305. QATAR GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 306. QATAR GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 307. QATAR GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 308. QATAR GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 309. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 310. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 311. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 312. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 313. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 314. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 315. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 316. RUSSIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 318. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 319. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 320. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 321. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 322. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 323. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 324. SAUDI ARABIA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 326. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 327. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 328. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 329. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 330. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 331. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 332. SOUTH AFRICA GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 333. SPAIN GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 334. SPAIN GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 335. SPAIN GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 336. SPAIN GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 337. SPAIN GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 338. SPAIN GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 339. SPAIN GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 340. SPAIN GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 341. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 342. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 343. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 344. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 345. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 346. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 347. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 348. SWEDEN GENETIC ANALYSIS MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 349. SWITZERLAND GENETIC ANALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 350. SWITZERLAND GENETIC ANALYSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR), 2018-2030 (USD MILLION)
  • TABLE 351. SWITZERLAND GENETIC ANALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 352. SWITZERLAND GENETIC ANALYSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 353. SWITZERLAND GENETIC ANALYSIS